WWL70

WWL70

CAT N°: 10011213
Price:

From €68.00 €57.80

WWL70 is an inhibitor of ?/?-hydrolase domain-containing protein 6 (ABHD6; IC50 = 70 nM).{15297} It increases the expression of the adipose browning-related gene Ucp1 in differentiated 3T3-L1 mouse adipocytes and increases the oxygen consumption rate (OCR), an effect that can be blocked by the PPAR? antagonist GW 6471 (Item No. 11697), when used at a concentration of 10 µM.{53349} WWL70 (10 mg/kg per day) also increases the expression of the adipose browning-related genes Ucp1, Prdm16, Tmem26, and Tbx1 in visceral adipose tissue in mice fed a high-fat diet. WWL70 reduces adipose tissue mass and prevents glucose-intolerance and increases in body weight in mice fed a high-fat diet but does not reduce hepatic triacylglycerol levels.{53350} It increases brain levels of 2-arachidonoyl glycerol (2-AG; Item No. 62160) and decreases the severity of experimental autoimmune encephalomyelitis (EAE) in wild-type, but not cannabinoid (CB) receptor 2 (CB2) knockout, mice when administered at a dose of 10 mg/kg per day starting at disease onset.{53351}

Territorial Availability: Available through Bertin Technologies only in France

  • Synonyms
    • N-methyl-N-[[3-(4-pyridinyl)phenyl]methyl]-carbamic acid, 4′-(aminocarbonyl)[1,1′-biphenyl]-4-yl ester
  • Correlated keywords
    • WWL-70 ABHD-6 Ucp-1 3T3L1 PPAR-? GW6471 Prdm-16 Tmem-26 Tbx-1 triacyl-glycerol 2AG
  • Product Overview:
    WWL70 is an inhibitor of ?/?-hydrolase domain-containing protein 6 (ABHD6; IC50 = 70 nM).{15297} It increases the expression of the adipose browning-related gene Ucp1 in differentiated 3T3-L1 mouse adipocytes and increases the oxygen consumption rate (OCR), an effect that can be blocked by the PPAR? antagonist GW 6471 (Item No. 11697), when used at a concentration of 10 µM.{53349} WWL70 (10 mg/kg per day) also increases the expression of the adipose browning-related genes Ucp1, Prdm16, Tmem26, and Tbx1 in visceral adipose tissue in mice fed a high-fat diet. WWL70 reduces adipose tissue mass and prevents glucose-intolerance and increases in body weight in mice fed a high-fat diet but does not reduce hepatic triacylglycerol levels.{53350} It increases brain levels of 2-arachidonoyl glycerol (2-AG; Item No. 62160) and decreases the severity of experimental autoimmune encephalomyelitis (EAE) in wild-type, but not cannabinoid (CB) receptor 2 (CB2) knockout, mice when administered at a dose of 10 mg/kg per day starting at disease onset.{53351}

We also advise you

Any project? Any challenge? We are in!
Contact us

Headquarters:
Parc d’activités du Pas du Lac
10 bis avenue Ampère

78180 Montigny le Bretonneux
France

Call us
Information
My account
Follow us

Copyright © 2024 BERTIN BIOREAGENT. All rights reserved | Terms & conditions

Secure payment
Subscribe to our newsletter